Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 1
1964 1
1967 1
1968 1
1970 1
1971 1
1972 2
1973 1
1974 2
1975 1
1976 1
1977 1
1978 1
1979 5
1980 2
1981 1
1984 1
1985 4
1986 2
1987 1
1988 1
1989 8
1990 2
1991 4
1992 4
1993 6
1994 9
1995 14
1996 11
1997 16
1998 16
1999 15
2000 12
2001 13
2002 7
2003 6
2004 13
2005 16
2006 33
2007 21
2008 23
2009 28
2010 28
2011 22
2012 45
2013 52
2014 34
2015 35
2016 50
2017 50
2018 56
2019 55
2020 59
2021 85
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

804 results
Results by year
Filters applied: . Clear all
Page 1
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H. Okuno Y, et al. Among authors: narita y. Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21. Nat Microbiol. 2019. PMID: 30664667
Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S, Yoshida T, Kojima Y, Yagishita S, Nakahama H, Okinaka K, Matsushita H, Shiotsuka M, Kobayashi O, Iwata S, Narita Y, Ohba A, Takahashi M, Iwasa S, Kobayashi K, Ohe Y, Yoshida T, Hamada A, Doi T, Yamamoto N. Yazaki S, et al. Among authors: narita y. JAMA Oncol. 2021 Aug 1;7(8):1141-1148. doi: 10.1001/jamaoncol.2021.2159. JAMA Oncol. 2021. PMID: 34047762
Antibody to CD137 Activated by Extracellular Adenosine Triphosphate Is Tumor Selective and Broadly Effective In Vivo without Systemic Immune Activation.
Kamata-Sakurai M, Narita Y, Hori Y, Nemoto T, Uchikawa R, Honda M, Hironiwa N, Taniguchi K, Shida-Kawazoe M, Metsugi S, Miyazaki T, Wada NA, Ohte Y, Shimizu S, Mikami H, Tachibana T, Ono N, Adachi K, Sakiyama T, Matsushita T, Kadono S, Komatsu SI, Sakamoto A, Horikawa S, Hirako A, Hamada K, Naoi S, Savory N, Satoh Y, Sato M, Noguchi Y, Shinozuka J, Kuroi H, Ito A, Wakabayashi T, Kamimura M, Isomura F, Tomii Y, Sawada N, Kato A, Ueda O, Nakanishi Y, Endo M, Jishage KI, Kawabe Y, Kitazawa T, Igawa T. Kamata-Sakurai M, et al. Among authors: narita y. Cancer Discov. 2021 Jan;11(1):158-175. doi: 10.1158/2159-8290.CD-20-0328. Epub 2020 Aug 25. Cancer Discov. 2021. PMID: 32847940 Free article.
Bevacizumab for glioblastoma.
Narita Y. Narita Y. Ther Clin Risk Manag. 2015 Dec 1;11:1759-65. doi: 10.2147/TCRM.S58289. eCollection 2015. Ther Clin Risk Manag. 2015. PMID: 26664126 Free PMC article. Review.
[Anti-PD-1].
Ohno M, Narita Y. Ohno M, et al. Among authors: narita y. Nihon Rinsho. 2016 Sep;74 Suppl 7:689-694. Nihon Rinsho. 2016. PMID: 30634834 Japanese. No abstract available.
Reverse Engineering Glioma Radiomics to Conventional Neuroimaging.
Kinoshita M, Kanemura Y, Narita Y, Kishima H. Kinoshita M, et al. Among authors: narita y. Neurol Med Chir (Tokyo). 2021 Sep 15;61(9):505-514. doi: 10.2176/nmc.ra.2021-0133. Epub 2021 Aug 6. Neurol Med Chir (Tokyo). 2021. PMID: 34373429 Free PMC article. Review.
804 results